Role of endocrine factors in the pathogenesis of cardiac hypertrophy.
D000172:Acromegaly / Q000150:complications*; D000818:Animals; D001835:Body Weight; D006332:Cardiomegaly / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D002395:Catecholamines / Q000378:metabolism; D004195:Disease Models, Animal; D013006:Growth Hormone / Q000378:metabolism; D006321:Heart / Q000503:physiopathology; D006892:Hydroxydopamines / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications; D006980:Hyperthyroidism / Q000150:complications*; D007545:Isoproterenol / Q000009:adverse effects; D007668:Kidney / Q000473:pathology; D008297:Male; D009929:Organ Size; D010673:Pheochromocytoma / Q000150:complications*; D051381:Rats; D013974:Thyroxine / Q000378:metabolism
D002395:Catecholamines; D006892:Hydroxydopamines; D013006:Growth Hormone; D007545:Isoproterenol; D013974:Thyroxine